Medicinal Biotechnology for Disease Modeling, Clinical Therapy, and Drug Discovery and Development
Robin Duelen,Marlies Corvelyn,Ilaria Tortorella,Leonardo Leonardi,Yoke Chin Chai,Maurilio Sampaolesi
DOI: https://doi.org/10.1007/978-3-030-22141-6_5
2019-01-01
Abstract:AbstractOver the past decades, stem cell technology has revolutionalized medical biotechnology due to the unlimited self-renewal ability and differentiation capacity of stem cells to generate cells and tissues of the entire human body. Many efforts have focused on providing cutting-edge stem cell therapies in order to repair or replace damaged cells or tissues, hoping to ultimately cure devastating diseases. Undoubtedly, this novel technology guarantees a serial entrepreneur’s confidence in the future prospects of stem cell-based products and services. Here, we describe the state of the art of several applications of adult stem cells, as well as of embryonic and induced pluripotent stem cells in biotechnology that represent entrepreneurial opportunities. Although the contribution of stem cells to medical research is enormous, several hurdles still have to be overcome, including ethical and regulatory issues, functional maturation of stem cell progenitors, stringent manufacturing guidelines, immune rejection, and tumorigenicity.Nevertheless, key studies applying microfluidic technology, “organ-in-a-dish” and 3D bioprinting have been published, reporting the successful development of human pluripotent stem cell-based healthy and disease models for deciphering pathological mechanisms, drug discovery and toxicity screening, and regenerative medicine. Interestingly, because of the increasing amount of newly identified targets, assistance from computational chemistry and bioinformatics became indispensable to reduce the quantity of molecules that need to be tested in vitro or in vivo. In the past years, a boom in companies and start-ups all over the world occurred, focusing on bioinformatics and machine learning. Furthermore, biotechnological applications are highly applied in the veterinary medicine nowadays, and stem cell-based biotechnology is opening an exciting era in human therapeutics. In conclusion, scientists with strong entrepreneur mind-set are crucial to generate economic value in medicinal biotechnology. Thus, we need to educate next generation of scientists in entrepreneurship and work directly with institutions and funding agencies to guarantee a successful translational process in hiring and training our next generation of students.